Pricing Log in Create free account

Sagimet Biosciences Inc. (SGMT) vs Silence Therapeutics PLC Sponsored ADR (SLN)

Sagimet Biosciences Inc. and Silence Therapeutics PLC Sponsored ADR are both Biotechnology companies. Sagimet Biosciences Inc. and Silence Therapeutics PLC Sponsored ADR are of similar size ($581.1M and $574.7M). Across the 10 metrics below, Sagimet Biosciences Inc. leads on 6 and Silence Therapeutics PLC Sponsored ADR on 4.

Valuation

Metric SGMT SLN Biotechnology median
P/E n/m n/m 8.50
P/S n/m 488.70 9.71
P/B 1.66 10.66 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 402.90 9.21
Earnings yield (15.96%) (14.75%) (33.15%)
Free cash flow yield (9.79%) (10.32%) (25.50%)

Profitability

Metric SGMT SLN Biotechnology median
Gross margin 0.00% 79.50% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (24.37%) (90.41%) (56.36%)
Return on assets (23.49%) (44.14%) (48.04%)
Return on invested capital (205.24%) 0.00% 0.00%

Growth

Metric SGMT SLN Biotechnology median
Revenue growth (TTM) — (96.97%) 6.02%
EPS growth (last fiscal year) (8.97%) (90.91%) 30.26%
Revenue growth, 5-year CAGR — (39.74%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SGMT SLN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 45.02 7.42 4.72
Net debt to EBITDA 1.98 0.94 0.96

Dividend

Metric SGMT SLN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric SGMT SLN Biotechnology median
Market cap 574.68m 581.10m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack